495 related articles for article (PubMed ID: 34627082)
21. Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
Kim N; Lee JM; Oh EJ; Jekarl DW; Lee DG; Im KI; Cho SG
Front Immunol; 2021; 12():751869. PubMed ID: 35003063
[TBL] [Abstract][Full Text] [Related]
22. Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2.
Low JS; Vaqueirinho D; Mele F; Foglierini M; Jerak J; Perotti M; Jarrossay D; Jovic S; Perez L; Cacciatore R; Terrot T; Pellanda AF; Biggiogero M; Garzoni C; Ferrari P; Ceschi A; Lanzavecchia A; Sallusto F; Cassotta A
Science; 2021 Jun; 372(6548):1336-1341. PubMed ID: 34006597
[TBL] [Abstract][Full Text] [Related]
23. Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2.
Shimizu K; Iyoda T; Sanpei A; Nakazato H; Okada M; Ueda S; Kato-Murayama M; Murayama K; Shirouzu M; Harada N; Hidaka M; Fujii SI
Commun Biol; 2021 Dec; 4(1):1365. PubMed ID: 34857854
[TBL] [Abstract][Full Text] [Related]
24. CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention.
Guo E; Guo H
PLoS One; 2020; 15(12):e0239566. PubMed ID: 33301503
[TBL] [Abstract][Full Text] [Related]
25. Identification of Novel Candidate CD8
Pushpakumara PD; Madhusanka D; Dhanasekara S; Jeewandara C; Ogg GS; Malavige GN
Viruses; 2021 May; 13(6):. PubMed ID: 34073934
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.
Grifoni A; Sidney J; Vita R; Peters B; Crotty S; Weiskopf D; Sette A
Cell Host Microbe; 2021 Jul; 29(7):1076-1092. PubMed ID: 34237248
[TBL] [Abstract][Full Text] [Related]
27. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.
Wu D; Kolesnikov A; Yin R; Guest JD; Gowthaman R; Shmelev A; Serdyuk Y; Dianov DV; Efimov GA; Pierce BG; Mariuzza RA
Nat Commun; 2022 Jan; 13(1):19. PubMed ID: 35013235
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.
Shomuradova AS; Vagida MS; Sheetikov SA; Zornikova KV; Kiryukhin D; Titov A; Peshkova IO; Khmelevskaya A; Dianov DV; Malasheva M; Shmelev A; Serdyuk Y; Bagaev DV; Pivnyuk A; Shcherbinin DS; Maleeva AV; Shakirova NT; Pilunov A; Malko DB; Khamaganova EG; Biderman B; Ivanov A; Shugay M; Efimov GA
Immunity; 2020 Dec; 53(6):1245-1257.e5. PubMed ID: 33326767
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8
Saini SK; Hersby DS; Tamhane T; Povlsen HR; Amaya Hernandez SP; Nielsen M; Gang AO; Hadrup SR
Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33853928
[TBL] [Abstract][Full Text] [Related]
30. Suboptimal SARS-CoV-2-specific CD8
Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
[TBL] [Abstract][Full Text] [Related]
31. Profiling CD8
Zhang H; Deng S; Ren L; Zheng P; Hu X; Jin T; Tan X
Cell Rep; 2021 Sep; 36(11):109708. PubMed ID: 34506741
[TBL] [Abstract][Full Text] [Related]
32. Characterization of pre-existing and induced SARS-CoV-2-specific CD8
Schulien I; Kemming J; Oberhardt V; Wild K; Seidel LM; Killmer S; Sagar ; Daul F; Salvat Lago M; Decker A; Luxenburger H; Binder B; Bettinger D; Sogukpinar O; Rieg S; Panning M; Huzly D; Schwemmle M; Kochs G; Waller CF; Nieters A; Duerschmied D; Emmerich F; Mei HE; Schulz AR; Llewellyn-Lacey S; Price DA; Boettler T; Bengsch B; Thimme R; Hofmann M; Neumann-Haefelin C
Nat Med; 2021 Jan; 27(1):78-85. PubMed ID: 33184509
[TBL] [Abstract][Full Text] [Related]
33. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
Reche PA
Front Immunol; 2020; 11():586984. PubMed ID: 33178220
[TBL] [Abstract][Full Text] [Related]
34. A Systematic, Unbiased Mapping of CD8
Stryhn A; Kongsgaard M; Rasmussen M; Harndahl MN; Østerbye T; Bassi MR; Thybo S; Gabriel M; Hansen MB; Nielsen M; Christensen JP; Randrup Thomsen A; Buus S
Front Immunol; 2020; 11():1836. PubMed ID: 32983097
[TBL] [Abstract][Full Text] [Related]
35. Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles.
Becerra-Artiles A; Calvo-Calle JM; Co MD; Nanaware PP; Cruz J; Weaver GC; Lu L; Forconi C; Finberg RW; Moormann AM; Stern LJ
Cell Rep; 2022 Jun; 39(11):110952. PubMed ID: 35675811
[TBL] [Abstract][Full Text] [Related]
36. Detection of IFNγ-Secreting CD4
Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
[TBL] [Abstract][Full Text] [Related]
37. High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4
Coulon PG; Prakash S; Dhanushkodi NR; Srivastava R; Zayou L; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Nesburn AB; Kuppermann BD; Bahraoui E; Vahed H; Gil D; Jones TM; Ulmer JB; BenMohamed L
Front Immunol; 2024; 15():1343716. PubMed ID: 38605956
[TBL] [Abstract][Full Text] [Related]
38. Impaired Priming of SARS-CoV-2-Specific Naive CD8
Gallerani E; Proietto D; Dallan B; Campagnaro M; Pacifico S; Albanese V; Marzola E; Marconi P; Caputo A; Appay V; Gavioli R; Nicoli F
Front Immunol; 2021; 12():693054. PubMed ID: 34326844
[TBL] [Abstract][Full Text] [Related]
39. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
PLoS Pathog; 2023 Jul; 19(7):e1011032. PubMed ID: 37498934
[TBL] [Abstract][Full Text] [Related]
40. Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm.
Boni C; Cavazzini D; Bolchi A; Rossi M; Vecchi A; Tiezzi C; Barili V; Fisicaro P; Ferrari C; Ottonello S
Front Immunol; 2021; 12():730051. PubMed ID: 34566990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
